Montserrat Barcelo Riera, Md

Growth Strategy Advisor Europe #SilverEconomy #Biotech #SoyEjeCon #SoyPromociona #BarcelóCG #SilverDreamer

📍 Greater Barcelona Metropolitan Area, Spain🔄 Updated September 2026💼 4 investments📅 8 years investing🗓 Last invested Apr 2025
VC🌍 Spain
4
Total investments
1
Early stage
2
Mid stage
0
Late stage
8y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Advisor&Investor
Apr 2025
IKI Health is a digital health company transforming the way professionals deliver lifestyle medicine and preventive care. Our SaaS platform empowers doctors, health coaches, and wellness clinics to: Prescribe personalized programs in exercise, nutrition, rest, and emotional balance. Monitor progress with unified physical and emotional data. Improve client adherence and outcomes while saving time. Recognized by Crunchbase as a future growth company and awarded by CaixaBank EmprendeXXI and SilverEco, IKI Health is on a mission to shift healthcare from fragmented, reactive treatment to proactive, data-driven prevention—improving both patient outcomes and professional efficiency.
Board Member
Jun 2019
Nuestra misión: EJE&CON promueve la presencia de las mujeres en los puestos de Alta Dirección y Consejos de Administración. Apostamos por el #talentoSINgénero. @AsocEyC #EJECON #digitalEyC EJECON.org
Strategic Advisor. Investor
Jan 2019
HumanITcare is a digital health company delivering a telemedicine platform for monitoring remotely real-life data of chronic patients using Artificial Intelligence. HumanITcare is improving clinical outcomes and reducing clinical costs by providing an accurate remote patient monitoring system.
Experience · 9 entries
All (9)
Investments (4)
Founder (2)
Board (2)
2025
Advisor&Investor
Apr 2025
IKI Health is a digital health company transforming the way professionals deliver lifestyle medicine and preventive care. Our SaaS platform empowers doctors, health coaches, and wellness clinics to: Prescribe personalized programs in exercise, nutrition, rest, and emotional balance. Monitor progress with unified physical and emotional data. Improve client adherence and outcomes while saving time. Recognized by Crunchbase as a future growth company and awarded by CaixaBank EmprendeXXI and SilverEco, IKI Health is on a mission to shift healthcare from fragmented, reactive treatment to proactive, data-driven prevention—improving both patient outcomes and professional efficiency.
2020
Lecturer
Oct 2020
”la Caixa” Foundation manages Welfare Projects promoting programmes, actions, studies, supports and equipment, individually or collectively, to contribute to the progress of individuals and society, with special emphasis on the most vulnerable groups. With over 110 years of history, ”la Caixa” Foundation maintains a budget of 500 million euros and promotes more than 50,000 activities each year with more than 10,500,000 beneficiaries, with a firm commitment to human rights, peace, justice and human dignity. Solidarity, integrity, humanism and transcendence are the values that accompany the ”la Caixa” Foundation to achieve sustainable social change and to create opportunities for people. ”la Caixa” Foundation is the 1st foundation in Spain and the 3rd in the world, which makes it an international point of reference.
2019
Board Member
Jun 2019
Nuestra misión: EJE&CON promueve la presencia de las mujeres en los puestos de Alta Dirección y Consejos de Administración. Apostamos por el #talentoSINgénero. @AsocEyC #EJECON #digitalEyC EJECON.org
Strategic Advisor. Investor
Jan 2019
HumanITcare is a digital health company delivering a telemedicine platform for monitoring remotely real-life data of chronic patients using Artificial Intelligence. HumanITcare is improving clinical outcomes and reducing clinical costs by providing an accurate remote patient monitoring system.
2018
Board Member
Oct 2018
Kymos is a CRO that provides development services for pharmaceutical, biotechnology, veterinary, fine chemistry, cosmetics and nutraceuticals industries. The main areas of activity are the following ones: i) Immunogenicity studies and immunoassay of innovative biological drugs, biosimilars and vaccines. ii) Bioanalysis in preclinical and clinical studies, including full bioequivalence studies. iii) Quality control, stability studies and analytical development of drug substances and drug products (physico-chemical and microbiological testing) iv) Process analytical technology services, using NIR and RAMAN and QbD strategies. Kymos is certified in GLPs and GMPs compliance and it has been authorized as partial manufacturer in quality control.
Show all 9 entries ↓
Investment activity
2018–2025 · 4 investments
201812019220251
Recent (last 2 years)Earlier